ConductScience.org, home

Paper9508149

Calcium carbonate and reduction of levothyroxine efficacy.

Schneyer CR. JAMA, 1998. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Calcium carbonate and reduction of levothyroxine efficacy. Papers, record 9508149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9508149

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Calcium carbonate and reduction of levothyroxine efficacy.
PubMed
Journal
JAMA
PubMed
Year
1998
PubMed
Publication types
Letter
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.79
iCite
Revised in PubMed
2019-07-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schneyer CRC R

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calcium CarbonateMajor topic
ThyroxineMajor topic
Drug Administration Schedule
Drug Interactions
Humans

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
38637816Prevalence and differences in the co-administration of drugs known to interact: an analysis of three distinct and large populations.BMC Med2024https://conductscience.org/library/papers/38637816PubMed
37384019Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review.Ther Clin Risk Manag2023https://conductscience.org/library/papers/37384019PubMed
33801406Levothyroxine Interactions with Food and Dietary Supplements-A Systematic Review.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/33801406PubMed
30919287
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
Endocrine2019https://conductscience.org/library/papers/30919287PubMed
30368654L-thyroxine malabsorption due to calcium carbonate impairs blood pressure, total cholesterolemia, and fasting glycemia.Endocrine2019https://conductscience.org/library/papers/30368654PubMed
29966512Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature.BMC Nephrol2018https://conductscience.org/library/papers/29966512PubMed
28535579Review of Heterotopic Thyroid Autotransplantation.Clin Exp Otorhinolaryngol2017https://conductscience.org/library/papers/28535579PubMed
28155174Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.Endocrine2017https://conductscience.org/library/papers/28155174PubMed
21595516Absorption of levothyroxine when coadministered with various calcium formulations.Thyroid2011https://conductscience.org/library/papers/21595516PubMed
10693372How medications affect thyroid function.West J Med2000https://conductscience.org/library/papers/10693372PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9508149

GET https://conductscience.org/api/papers/v1/9508149/authors